Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD20”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06735664
What this trial is testing

Zanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation

Who this might be right for
Recurrent Transformed Chronic Lymphocytic LeukemiaRefractory Transformed Chronic Lymphocytic LeukemiaRichter Syndrome+1 more
City of Hope Medical Center 23
Large-scale testing (Phase 3)Study completedNCT04486716
What this trial is testing

A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 111
Testing effectiveness (Phase 2)UnknownNCT05805943
What this trial is testing

Study of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's Lymphoma

Who this might be right for
CD20-positive B-cell Non-Hodgkin's Lymphoma
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 154
Large-scale testing (Phase 3)Study completedNCT02747043
What this trial is testing

Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab

Who this might be right for
Lymphoma, Non-Hodgkin
Amgen 256
Testing effectiveness (Phase 2)Temporarily pausedNCT03704714
What this trial is testing

Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma

Who this might be right for
Aggressive Non-Hodgkin LymphomaB-Cell Non-Hodgkin LymphomaCD20 Positive+5 more
Northwestern University 30
Early research (Phase 1)Looking for participantsNCT05418088
What this trial is testing

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Who this might be right for
Recurrent Acute Lymphoblastic LeukemiaRecurrent B Acute Lymphoblastic LeukemiaRecurrent B-Cell Prolymphocytic Leukemia+15 more
Sumithira Vasu 54
Not applicableStudy completedNCT04519710
What this trial is testing

Specific Anti-HBV Vaccine Response After Vaccination in Patients Requiring Anti-CD20 Monoclonal Antibodies

Who this might be right for
HBV
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida 60
Very early researchNot Yet RecruitingNCT07546110
What this trial is testing

An Open-Label, Single-Arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of CD20 Monoclonal Antibody Combined With NK042 Cell Injection in the Treatment of Multiple Sclerosis (MS).

Who this might be right for
Multiple Sclerosis
The Affiliated Hospital of Xuzhou Medical University 20
Large-scale testing (Phase 3)Study completedNCT04361279
What this trial is testing

A Study Comparing SIBP-02 and Rituximab Combination With CHOP in Previously Untreated Subjects With CD20+ DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma
Shanghai Institute Of Biological Products 421
Testing effectiveness (Phase 2)Ended earlyNCT01434472
What this trial is testing

High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma

Who this might be right for
Post-Transplant Lymphoproliferative DisorderRecurrent Adult Diffuse Large Cell LymphomaRecurrent B-Cell Non-Hodgkin Lymphoma+4 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT07321301
What this trial is testing

Polymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory B-cell Lymphoma/Leukemia

Who this might be right for
B-cell Lymphoma Refractory
Daihong Liu 10
Very early researchNot Yet RecruitingNCT07546630
What this trial is testing

Nanobody-Based CD19/CD20 Tandem Dual CAR-T-cell Therapy of Relapsed/Refractory B-Cell Lymphoma

Who this might be right for
Relapsed/Refractory B-Cell Lymphoma
Affiliated Hospital to Academy of Military Medical Sciences 20
Early research (Phase 1)UnknownNCT01858181
What this trial is testing

Phase I Study of Subcutaneous Ocaratuzumab in Patients With Previously Treated CD20+ B-Cell Malignancies

Who this might be right for
Previously Treated CD20+ B-cell Malignancies
Mentrik Biotech, LLC 9
Testing effectiveness (Phase 2)Study completedNCT01015248
What this trial is testing

Trial of Bendamustine And Rituximab for Patients With Previously Untreated Extranodal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma

Who this might be right for
MALT LYMPHOMA
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 60
Testing effectiveness (Phase 2)Study completedNCT00307125
What this trial is testing

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

Who this might be right for
Kidney TransplantKidney Transplant RecipientGraft Function/Survival+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 757
Early research (Phase 1)Ended earlyNCT06295549
What this trial is testing

Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
The First Affiliated Hospital with Nanjing Medical University 11
Testing effectiveness (Phase 2)Looking for participantsNCT07493148
What this trial is testing

Chidamide Combination With R-mini CHOP Followed by Chidamide+CD20 Maintenance in Elderly Newly Diagnosed MYC/BCL2+ DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
Ou Bai, MD/PHD 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04663347
What this trial is testing

Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)

Who this might be right for
Diffuse Large B-Cell LymphomaFollicular Lymphoma
Genmab 543
Large-scale testing (Phase 3)Looking for participantsNCT07189325
What this trial is testing

A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis (RRMS)Anti-CD20 Therapy
University Hospital, Montpellier 250
Early research (Phase 1)Not Yet RecruitingNCT07166549
What this trial is testing

Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)

Who this might be right for
B Cell MalignanciesB-cell LeukemiaB Cell Lymphoma+2 more
University Hospital, Basel, Switzerland 12
Next Page